Recent Advances in Genetic Studies on Leukemia
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: closed (30 March 2025) | Viewed by 3502
Special Issue Editor
Interests: hematologic neoplasms; cancer genetics; molecular diagnostics; target therapy; precision medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The classification of hematological tumors is periodically updated by collecting discoveries generated from the research studies of pathologists, geneticists, hematologists, and oncologists. Recently, the most current and clinically significant data have been utilized to revise and update the classifications of myeloid malignancies and acute leukemias; these data included the biology of hematologic neoplasms, their management in clinical practice, and results from clinical trials. Due to the crucial role of genetic features in defining a patient’s diagnosis, studying the genetic bases of leukemia heterogeneity ensures that biologic peculiarities and vulnerabilities are explored thoroughly, and this is essential for recognizing more active therapeutic treatments, identifying resistance mechanisms and early response markers, and improving cure possibilities.
Considering the importance of this topic, I am pleased to invite the submission of original research articles and review articles which can broaden our knowledge regarding the genetic basis of hematological pathologies, with a special focus on leukemia.
I look forward to receiving your contributions.
Dr. Nicoletta Coccaro
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hematologic neoplasms
- leukemia
- cancer genetics
- precision medicine
- target therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
